Following an internal investigation, the article referenced above has been found to contain inappropriate manipulation of bands in gels within Figures 2A, 3A, and 4. Molecular Pharmacology has retracted this article.
. 2015 Aug;88(2):390. doi: 10.1124/mol.115.08er15a
Re: Ling Y-H, Li T, Yuan Z, Haigentz M, Jr., Weber TK, and Perez-Soler R (2007) Erlotinib, an Effective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces p27KIP1 Up-Regulation and Nuclear Translocation in Association with Cell Growth Inhibition and G1/S Phase Arrest in Human Non-Small-Cell Lung Cancer Cell Lines. Mol Pharmacol 72:248–258; doi:10.1124/mol.107.034827
Issue date 2015 Aug.
Copyright © 2015 The American Society for Pharmacology and Experimental Therapeutics
PMCID: PMC4518090 PMID: 26130289
This retracts the article "Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines." in volume 72 on page 248.